Mitochondrial Complex V Atp Synthase Deficiency Nuclear Type 5 C4748269
A rare genetic disorder affecting mitochondria, the energy-producing structures in cells. It impairs energy generation, primarily affecting muscles, brain, and heart. Treatment focuses on symptom management and supportive care.
Key facts at a glance
- ICD-10
- E88.9
- ICD-11
- 5A00.0
- Body system
- metabolic
- Severity
- severe
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Warning signs - seek immediate care
Lactic acidosis
Seizures
Fatigue or weight changes
(metabolic)Significant symptoms that substantially affect daily functioning.
Frequency: Common at all stages
Motor developmental delay
(metabolic)Sensorineural hearing loss
(metabolic)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Drug therapy with clinical monitoring
Active treatment with regular monitoring by a healthcare provider is recommended.
Mitochondrial disease cocktail
Combination therapy including CoQ10, L-carnitine, B-complex vitamins, and alpha-lipoic acid tailored to individual patient needs for comprehensive mitochondrial support.
Multisystem surveillance program
Comprehensive monitoring of cardiac, neurological, endocrine, and hepatic systems due to the systemic nature of complex V deficiency type 5.
Additional treatment options
Cardiac device implantation
For patients developing cardiomyopathy or arrhythmias, pacemakers or defibrillators may be necessary to manage cardiac complications of mitochondrial disease.
surgicalRespiratory muscle training
Targeted exercises to maintain respiratory muscle strength, which may be affected in mitochondrial myopathy. Includes incentive spirometry and breathing exercises.
physical_therapyPhotobiomodulation therapy
Low-level light therapy to potentially improve mitochondrial function and reduce cellular stress. Emerging therapy with promising preliminary results.
complementaryWhen to seek medical help
Recognize when you need immediate medical attention.
See a doctor within 24 hours
Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.
Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.
Frequently asked questions
Common questions about this topic.
What is Mitochondrial Complex V Atp Synthase Deficiency Nuclear Type 5 C4748269?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalMedication Comparisons
Compare medications used to treat Mitochondrial Complex V Atp Synthase Deficiency Nuclear Type 5 C4748269. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy